📦 NDC / package directory — not a drug information page
Ocrelizumab NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Ocrelizumab products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
4
Package NDCs
4
Products
4
Active listings
0
Discontinued
2
Labelers
3
Strengths
2
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| ocrelizumab 55 mg/mL LIQUID | 67643-7000-01 | — | On market | View → |
| ocrelizumab 55 g/L LIQUID | 67643-7001-01 | — | On market | View → |
| ocrelizumab 55 g/L LIQUID | 67643-7001-01 | — | On market | View → |
| OCREVUS ocrelizumab 300 mg/10mL INJECTION | 50242-0150-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.